• Home
  • about
  • contact
  • twitter
  • archive
  • RSS

Stem Cell Assays

RegenMed digest

Is FDA slowing down the progress in clinical cell therapy?

by Alexey Bersenev on November 27, 2011 · 1 comment

in cell product,RegenMed digest

Educational resources for cell therapy professionals

by Alexey Bersenev on November 21, 2011 · 0 comments

in cell product,educational,RegenMed digest

Regenerative medicine industry – worthwhile investment or not?

by Alexey Bersenev on September 6, 2011 · 0 comments

in RegenMed digest

Regenerative medicine progress in regions

by Alexey Bersenev on August 15, 2011 · 2 comments

in RegenMed digest

Recent notable approvals in regenerative medicine

by Alexey Bersenev on July 25, 2011 · 1 comment

in RegenMed digest

Point-of-care cell processing devices in clinical trials

by Alexey Bersenev on July 12, 2011 · 5 comments

in cell separation,RegenMed digest

RegenMed industry and Big Pharma – love-hate relationships?

by Alexey Bersenev on July 5, 2011 · 0 comments

in RegenMed digest

Cell therapy industry – market size and more predictions

by Alexey Bersenev on May 29, 2011 · 0 comments

in RegenMed digest

More opportunities for career in regenerative medicine

by Alexey Bersenev on May 16, 2011 · 0 comments

in RegenMed digest

Career in regenerative medicine and life sciences – some advices

by Alexey Bersenev on April 28, 2011 · 0 comments

in RegenMed digest

← Previous Entries

Next Entries →

  • search

  • follow updates:

    • subscribe via RSS
    • Enter your email address:

  • advertisement

  • our partners:



  • categories

    • adipose (6)
    • cancer (33)
    • cell culture (24)
    • cell product (46)
    • cell separation (8)
    • clinical lab (19)
    • consensus (11)
    • cord blood (16)
    • cytometry (22)
    • direct reprogramming (12)
    • educational (21)
    • embryonic/iPS (65)
    • events (7)
    • gadgets (8)
    • gene transfer (6)
    • hematopoietic (70)
    • interviews (10)
    • lectures (36)
    • mesenchymal (34)
    • methods (30)
    • neural (14)
    • notes (38)
    • open science (24)
    • other adult stem cells (13)
    • protocols (53)
    • RegenMed digest (28)
    • reviews (40)
    • tissue engineering (11)
    • web tools (10)
  • series:

    Experimental bone marrow transplantation 101

    Methods and Protocols Digest

    Mesenchymal Stem Cells – definition and assays

    True Blood - manufacturing blood from stem cells

    RegenMed Digest - industry updates

  • featured posts:

    The definition of stem cell therapy

    10 companies to watch in 2012

    Series of retractions from Amy Wagers’ stem cell lab

    Genomic stability of clinical-grade mesenchymal stromal cells – a proposal for international initiative

    Stem Cell Assays in 2011

  • polls:

    The next generation of potency assays for hematopoietic graft

    What is the correct name for “mesenchymal stem cells”?

    What is the most promising method for targeting cancer stem cells?

    True blood: What approach is more promising for blood manufacturing?

  • recent comments

    • Michael An on Clinical cell processing news – part 1
    • Alexey Bersenev on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • Alexey Bersenev on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • Owen Bain on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • James Eliason on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
  • blogs we recommend:

    Hematopoiesis
    Knoepfler Lab Stem Cell Blog
    Cell Therapy Blog
    Stem Cell Treatment Monitor
    Stem Cell Network Blog
    The Cell Culture Dish

  • popular tags:

    assay BMT model business cancer cancer stem cell CD34 cell culture cell processing cell product cell separation cell therapy clinical-grade clinical trial collaboration conference cord blood direct transdifferentiation embryonic stem cell flow cytometry guidelines HSC HSC isolation iPS jove lecture manufacturing marker market method MSC MSC isolation neural stem cell open science pluripotency progenitor protocol regenerative medicine RegenMed reprogramming review risk safety tissue engineering video xeno
  • cell therapy trials tracking:

  • databases:

    Cell Image Library Reference

    Stem Cell Lineage Database

    Characterization Tool

    European Human Embryonic Stem Cell Registry

    PluriTest

    StemBase

    StemDB

  • license:

    Creative Commons License
    This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License.
  • Ads

Get smart with the Thesis WordPress Theme from DIYthemes.

WordPress Admin